| |
 |
ARTICLES 
|
|
| Preoperative chemotherapy and breast-conserving therapy: why not everyone? |
| A Recht |
|
JCO Jul 1 1997: 2479–2482.
[PDF]
|
 |
|
Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18 |
| |
B Fisher, A Brown, E Mamounas, S Wieand, A Robidoux, RG Margolese, AB Cruz, Jr, ER Fisher, DL Wickerham, N Wolmark, A DeCillis, JL Hoehn, AW Lees, and NV Dimitrov |
| |
JCO Jul 1 1997: 2483–2493.
[Abstract]
[PDF]
|
|
|
Megestrol acetate and aminoglutethimide/hydrocortisone in sequence or in combination as second-line endocrine therapy of estrogen receptor- positive metastatic breast cancer: a Southwest Oncology Group phase III trial |
| |
CA Russell, SJ Green, J O'Sullivan, HE Hynes, GT Budd, JE Congdon, S Martino, and CK Osborne |
| |
JCO Jul 1 1997: 2494–2501.
[Abstract]
[PDF]
|
|
|
Adjuvant chemotherapy in operable breast cancer: cyclophosphamide, methotrexate, and fluorouracil versus chlorambucil, methotrexate, and fluorouracil--11-year results of Swiss Group for Clinical Cancer Research trial SAKK 27/82 |
| |
HJ Senn, R Maibach, M Castiglione, WF Jungi, F Cavalli, S Leyvraz, JP Obrecht, O Schildknecht, and P Siegenthaler |
| |
JCO Jul 1 1997: 2502–2509.
[Abstract]
[PDF]
|
|
|
Dose-finding study and pharmacokinetics of epirubicin and paclitaxel over 3 hours: a regimen with high activity and low cardiotoxicity in advanced breast cancer |
| |
PF Conte, E Baldini, A Gennari, A Michelotti, B Salvadori, C Tibaldi, R Danesi, F Innocenti, A Gentile, R Dell'Anna, O Biadi, M Mariani, and M Del Tacca |
| |
JCO Jul 1 1997: 2510–2517.
[Abstract]
[PDF]
|
|
|
Prediction of response to antiestrogen therapy in advanced breast cancer patients by pretreatment circulating levels of extracellular domain of the HER-2/c-neu protein |
| |
H Yamauchi, A O'Neill, R Gelman, W Carney, DY Tenney, S Hosch, and DF Hayes |
| |
JCO Jul 1 1997: 2518–2525.
[Abstract]
[PDF]
|
|
|
Overview of randomized perioperative polychemotherapy trials in women with early-stage breast cancer |
| |
PC Clahsen, CJ van de Velde, A Goldhirsch, J Rossbach, MR Sertoli, L Bijnens, and RJ Sylvester |
| |
JCO Jul 1 1997: 2526–2535.
[Abstract]
[PDF]
|
|
|
Imaging of estrogen receptors in primary and metastatic breast cancer patients with iodine-123-labeled Z-MIVE |
| |
LJ Rijks, PJ Bakker, G van Tienhoven, LA Noorduyn, GJ Boer, RC Rietbroek, CW Taat, AG Janssen, CH Veenhof, and EA van Royen |
| |
JCO Jul 1 1997: 2536–2545.
[Abstract]
[PDF]
|
|
|
High-dose carboplatin, etoposide, and cyclophosphamide with autologous bone marrow transplantation in first-line therapy for patients with poor-risk germ cell tumors |
| |
RJ Motzer, M Mazumdar, DF Bajorin, GJ Bosl, P Lyn, and V Vlamis |
| |
JCO Jul 1 1997: 2546–2552.
[Abstract]
[PDF]
|
|
|
Long-term follow-up of patients with good-risk germ cell tumors treated with etoposide and cisplatin |
| |
H Xiao, M Mazumdar, DF Bajorin, M Sarosdy, V Vlamis, J Spicer, J Ferrara, GJ Bosl, and RJ Motzer |
| |
JCO Jul 1 1997: 2553–2558.
[Abstract]
[PDF]
|
|
|
Ifosfamide- and cisplatin-containing chemotherapy as first-line salvage therapy in germ cell tumors: response and survival |
| |
JA McCaffrey, M Mazumdar, DF Bajorin, GJ Bosl, V Vlamis, and RJ Motzer |
| |
JCO Jul 1 1997: 2559–2563.
[Abstract]
[PDF]
|
|
|
Long-term follow-up of a phase III intergroup study of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study |
| |
SB Saxman, KJ Propert, LH Einhorn, ED Crawford, I Tannock, D Raghavan, Sr Loehrer PJ, and D Trump |
| |
JCO Jul 1 1997: 2564–2569.
[Abstract]
[PDF]
|
|
|
Correlation between thymidine phosphorylase expression and prognosis in human renal cell carcinoma |
| |
Y Imazano, Y Takebayashi, K Nishiyama, S Akiba, K Miyadera, Y Yamada, S Akiyama, and Y Ohi |
| |
JCO Jul 1 1997: 2570–2578.
[Abstract]
[PDF]
|
|
|
Interferon alfa-2a and interleukin-2 with or without cisplatin in metastatic melanoma: a randomized trial of the European Organization for Research and Treatment of Cancer Melanoma Cooperative Group |
| |
U Keilholz, SH Goey, CJ Punt, TM Proebstle, R Salzmann, C Scheibenbogen, D Schadendorf, D Lienard, A Enk, R Dummer, B Hantich, AM Geueke, and AM Eggermont |
| |
JCO Jul 1 1997: 2579–2588.
[Abstract]
[PDF]
|
|
|
Treatment of ocular melanoma metastatic to the liver by hepatic arterial chemotherapy |
| |
S Leyvraz, V Spataro, J Bauer, S Pampallona, R Salmon, T Dorval, R Meuli, M Gillet, F Lejeune, and L Zografos |
| |
JCO Jul 1 1997: 2589–2595.
[Abstract]
[PDF]
|
|
|
Phase II study of continuous infusion carmustine and cisplatin followed by cranial irradiation in adults with newly diagnosed high-grade astrocytoma |
| |
SA Grossman, M Wharam, V Sheidler, L Kleinberg, M Zeltzman, N Yue, and S Piantadosi |
| |
JCO Jul 1 1997: 2596–2603.
[Abstract]
[PDF]
|
|
|
Tumoral-reduced folates and clinical resistance to fluorouracil-based treatment in head and neck cancer patients |
| |
S Cheradame, MC Etienne, P Formento, M Schneider, O Dassonville, F Demard, and G Milano |
| |
JCO Jul 1 1997: 2604–2610.
[Abstract]
[PDF]
|
|
|
Ewing's sarcoma and primitive neuroectodermal tumor in adults: are they different from Ewing's sarcoma and primitive neuroectodermal tumor in children? |
| |
MW Verrill, IR Judson, CL Harmer, C Fisher, JM Thomas, and E Wiltshaw |
| |
JCO Jul 1 1997: 2611–2621.
[Abstract]
[PDF]
|
|
|
Does histology influence outcome in childhood Hodgkin's disease? Results from the United Kingdom Children's Cancer Study Group |
| |
AG Shankar, S Ashley, M Radford, A Barrett, D Wright, and CR Pinkerton |
| |
JCO Jul 1 1997: 2622–2630.
[Abstract]
[PDF]
|
|
|
Use of chest computed tomography in the staging of pediatric Wilms' tumor: interobserver variability and prognostic significance |
| |
JA Wilimas, SC Kaste, WM Kauffman, H Winer-Muram, R Morris, X Luo, and JM Boyett |
| |
JCO Jul 1 1997: 2631–2635.
[Abstract]
[PDF]
|
|
|
EMA/CO for high-risk gestational trophoblastic tumors: results from a cohort of 272 patients [published erratum appears in J Clin Oncol 1997 Sep;15(9):3168] |
| |
M Bower, ES Newlands, L Holden, D Short, C Brock, GJ Rustin, RH Begent, and KD Bagshawe |
| |
JCO Jul 1 1997: 2636–2643.
[Abstract]
[PDF]
|
|
|
Access to bone marrow transplantation for leukemia and lymphoma: the role of sociodemographic factors |
| |
JM Mitchell, KR Meehan, J Kong, and KA Schulman |
| |
JCO Jul 1 1997: 2644–2651.
[Abstract]
[PDF]
|
|
|
Randomized trial of CVPP for three versus six cycles in favorable- prognosis and CVPP versus AOPE plus radiotherapy in intermediate- prognosis untreated Hodgkin's disease |
| |
S Pavlovsky, E Schvartzman, F Lastiri, H Magnasco, C Corrado, E Raslawski, ME Cancela, MC Ardaiz, I Cerutti, A Rosso, S Bruno, PN Aranguren, A Salvarezza, H Donato, E Dibar, and S Zirone |
| |
JCO Jul 1 1997: 2652–2658.
[Abstract]
[PDF]
|
|
|
Unique role of cytogenetics in the prognosis of patients with myeloma receiving high-dose therapy and autotransplants |
| |
G Tricot, JR Sawyer, S Jagannath, KR Desikan, D Siegel, S Naucke, S Mattox, D Bracy, N Munshi, and B Barlogie |
| |
JCO Jul 1 1997: 2659–2666.
[Abstract]
[PDF]
|
|
|
Treatment of T-cell prolymphocytic leukemia with human CD52 antibody |
| |
R Pawson, MJ Dyer, R Barge, E Matutes, PD Thornton, E Emmett, JC Kluin-Nelemans, WE Fibbe, R Willemze, and D Catovsky |
| |
JCO Jul 1 1997: 2667–2672.
[Abstract]
[PDF]
|
|
|
Cost-effectiveness of interferon alfa in chronic myelogenous leukemia |
| |
NL Liberato, S Quaglini, and G Barosi |
| |
JCO Jul 1 1997: 2673–2682.
[Abstract]
[PDF]
|
|
|
Detection of hepatocellular carcinoma with a new alpha-fetoprotein antibody imaging kit |
| |
S Dresel, CM Kirsch, K Tatsch, R Zachoval, K Hahn, and DM Goldenberg |
| |
JCO Jul 1 1997: 2683–2690.
[Abstract]
[PDF]
|
|
|
Phase I and pharmacokinetic study of an oral platinum complex given daily for 5 days in patients with cancer |
| |
MJ McKeage, F Raynaud, J Ward, C Berry, D O'Dell, LR Kelland, B Murrer, P Santabarabara, KR Harrap, and IR Judson |
| |
JCO Jul 1 1997: 2691–2700.
[Abstract]
[PDF]
|
|
|
Limitations of reverse-transcriptase polymerase chain reaction analyses for detection of micrometastatic epithelial cancer cells in bone marrow |
| |
A Zippelius, P Kufer, G Honold, MW Kollermann, R Oberneder, G Schlimok, G Riethmuller, and K Pantel |
| |
JCO Jul 1 1997: 2701–2708.
[Abstract]
[PDF]
|
|
|
Low-dose urokinase infusions to treat fibrinous obstruction of venous access devices in cancer patients |
| |
MK Horne, 3rd and DJ Mayo |
| |
JCO Jul 1 1997: 2709–2714.
[Abstract]
[PDF]
|
|
|
Randomized phase III trial evaluating the role of erythropoietin in the prevention of chemotherapy-induced anemia |
| |
L Del Mastro, M Venturini, R Lionetto, O Garrone, G Melioli, W Pasquetti, MR Sertoli, G Bertelli, G Canavese, M Costantini, and R Rosso |
| |
JCO Jul 1 1997: 2715–2721.
[Abstract]
[PDF]
|
|
|
Are there sex biases in standardized tests of radiation oncology knowledge? |
| |
EC Halperin and GJ Broadwater |
| |
JCO Jul 1 1997: 2722–2727.
[Abstract]
[PDF]
|
|
|
Irradiation in the setting of collagen vascular disease: acute and late complications |
| |
MM Morris and SN Powell |
| |
JCO Jul 1 1997: 2728–2735.
[Abstract]
[PDF]
|
|
|
Role of independent data-monitoring committees in randomized clinical trials sponsored by the National Cancer Institute |
| |
MA Smith, RS Ungerleider, EL Korn, L Rubinstein, and R Simon |
| |
JCO Jul 1 1997: 2736–2743.
[Abstract]
[PDF]
|
|
|
Brain tumor-polyposis syndrome: two genetic diseases? |
| |
F Paraf, S Jothy, and EG Van Meir |
| |
JCO Jul 1 1997: 2744–2758.
[Abstract]
[PDF]
|
|
| Hypertrophic osteoarthropathy |
| HJ Burstein, MJ Janicek, and AT Skarin |
|
JCO Jul 1 1997: 2759–2760.
[PDF]
|
|
| Low-grade glioma--the Europeans are winning! |
| C Leighton and G Cairncross |
|
JCO Jul 1 1997: 2761a.
[PDF]
|
|
| Claims-based 'report card' deserves failing grade |
| MJ Cornfeld |
|
JCO Jul 1 1997: 2761b.
[PDF]
|
|
| Trial etiquette |
| JG McVie |
|
JCO Jul 1 1997: 2761c–2762.
[PDF]
|
|
